# Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

> **NCT00006029** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 91 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **DRUG:** pegylated liposomal doxorubicin hydrochloride
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00006029
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2016-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006029, "Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*